{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T22:09:12Z","timestamp":1793916552622,"version":"4.8.0"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2022,8,5]],"date-time":"2022-08-05T00:00:00Z","timestamp":1659657600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8,5]]},"abstract":"<jats:p>Heart failure leading to cardiac ascites is an extremely rare and underrecognized entity in clinical practice. Recognizing cardiac ascites can be difficult, especially since patients presenting with ascites may have more than 1 etiology. Various biomarkers are available to aid in the diagnosis of cardiac ascites, though with differing sensitivities and specificities. Such biomarkers include serum albumin, ascitic albumin and protein, as well as serum N-terminal pro-brain natriuretic peptide (NT-proBNP). While serum NT-proBNP is a powerful biomarker in distinguishing the etiology of ascites and monitoring treatment progression, its cost can be prohibitive in low-resource settings. Clinicians practicing under these circumstances may opt to rely on other parameters to manage their patients. We go on further to report a series of 3 patients with cardiac ascites to illustrate how these biomarkers may be employed in the management of this patient population. Clinicians should always keep in mind the differential diagnosis of cardiac failure as a cause of ascites. The resolution of cardiac ascites may serve as a surrogate clinical marker for response to antifailure therapy in lieu of NT-proBNP at resource-scarce centers.<\/jats:p>","DOI":"10.1097\/md.0000000000029951","type":"journal-article","created":{"date-parts":[[2022,8,9]],"date-time":"2022-08-09T14:09:29Z","timestamp":1660054169000},"page":"e29951","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["At the heart of the problem: congestive cardiac failure as a cause of ascites: A narrative review"],"prefix":"10.1097","volume":"101","author":[{"given":"Zhong Ning Leonard","family":"Goh","sequence":"first","affiliation":[{"name":"Department of Medicine, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland Yii Lin","family":"Teo","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bui Khiong","family":"Chung","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis Ching","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine, Sarawak General Hospital, Ministry of Health, Kuching, Sarawak, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0984-8385","authenticated-orcid":false,"given":"Chen-June","family":"Seak","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan"},{"name":"Department of Emergency Medicine, Lin-Kou Medical Center, Chang Gung Memorial Hospital, Taoyuan, Taiwan"},{"name":"College of Medicine, Chang Gung University, Taoyuan, Taiwan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites","volume":"117","author":"Runyon","year":"1992","journal-title":"Ann Intern Med"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/j.1365-2036.2005.02691.x","article-title":"Systematic review: the model for end-stage liver disease \u2013 should it replace Child-Pugh\u2019s classification for assessing prognosis in cirrhosis?","volume":"22","author":"Cholongitas","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/S1089-3261(02)00056-9","article-title":"The liver in heart failure","volume":"6","author":"Giallourakis","year":"2002","journal-title":"Clin Liver Dis"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4254\/wjh.v6.i1.41","article-title":"Hepato-cardiac disorders","volume":"6","author":"Fouad","year":"2014","journal-title":"World J Hepatol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/0016-5085(88)90441-6","article-title":"Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites","volume":"94","author":"Llach","year":"1988","journal-title":"Gastroenterology"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4254\/wjh.v5.i5.251","article-title":"Cirrhotic ascites review: Pathophysiology, diagnosis and management","volume":"5","author":"Moore","year":"2013","journal-title":"World J Hepatol"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"215","DOI":"10.7326\/0003-4819-117-3-215","article-title":"The serum-ascites albumin gradient is superior to the exudate-transudate concept in the differential diagnosis of ascites","volume":"117","author":"Runyon","year":"1992","journal-title":"Ann Intern Med"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1080\/00365520701272433","article-title":"Characteristics of ascitic fluid in cardiac ascites","volume":"42","author":"Christou","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/00004836-198808000-00013","article-title":"Cardiac ascites: a characterization","volume":"10","author":"Runyon","year":"1988","journal-title":"J Clin Gastroenterol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1001\/jama.2020.10262","article-title":"Heart failure with reduced ejection fraction: a review","volume":"325","author":"Murphy","year":"2020","journal-title":"JAMA"},{"key":"R15-20250504","first-page":"582","article-title":"Heart failure with preserved ejection fraction: diagnosis and management","volume":"96","author":"Gazewood","year":"2017","journal-title":"Am Fam Physician"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/CIRCRESAHA.118.312706","article-title":"Established and Emerging Roles of Biomarkers in Heart Failure","volume":"123","author":"Ibrahim","year":"2018","journal-title":"Circ Res"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1002\/ejhf.592","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"18","author":"Ponikowski","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"553533","DOI":"10.1007\/s10741-014-9451-x","article-title":"B-type natriuretic peptide-guided therapy: a systematic review","volume":"19","author":"Balion","year":"2014","journal-title":"Heart Fail Rev"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/eurheartj\/ehu090","article-title":"Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis","volume":"35","author":"Troughton","year":"2014","journal-title":"Eur Heart J"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2459\/JCM.0b013e328364bde1","article-title":"B-type natriuretic peptide-guided versus symptom-guided therapy in outpatients with chronic heart failure: a systematic review with meta-analysis","volume":"15","author":"De Vecchis","year":"2014","journal-title":"J Cardiovasc Med (Hagerstown)"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T04:29:15Z","timestamp":1746332955000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000029951"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,5]]},"references-count":18,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000029951","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,5]]}}}